Pliant Therapeutics Inc (PLRX)
NASDAQ
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -105.674 | -7.388 | -20.036 | -37.645 | -43.132 | -37.4 |
Return on Equity (%) | 98.37 | 9.28 | -40.174 | -40.348 | -48.135 | -41.005 |
Return on Invested Capital (%) | -102.882 | -1.474 | -21.384 | -40.569 | -48.82 | -45.771 |
Operating Margin (%) | N/A | -1.106 | -99.321 | -1284.509 | -1265.152 | -10130.949 |
Net Profit Margin (%) | N/A | -12.017 | -99.321 | -1284.509 | -1273.32 | -10211.139 |
Book Value Per Share | 6.222 | 8.332 | 7.962 | 5.517 | 6.402 | 7.907 |
Earnings Per Share | -3.607 | -0.519 | -1.168 | -2.696 | -2.52 | -2.694 |
Cash Per Share | 6.254 | 6.501 | 1.431 | 1.432 | 0.688 | 1.056 |
Working Capital Per Share | 5.813 | 7.859 | 7.852 | 5.338 | 6.465 | 7.963 |
Operating Profit Per Share | N/A | 4.322 | 1.176 | 0.21 | 0.198 | 0.026 |
EBIT Per Share | -3.107 | -0.048 | -1.168 | -2.696 | -2.52 | -2.694 |
EBITDA Per Share | -3.107 | -0.048 | -1.168 | -2.696 | -2.52 | -2.694 |
Free Cash Flow Per Share | -3.437 | -0.531 | -1.162 | -2.684 | -2.521 | -2.709 |
Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 9.75M | 13.2M | 35.55M | 36.08M | 48.94M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
Shares Outstanding | 48.75M | 48.94M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -2795.571 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -2818.919 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 789.88M |
Price to Earnings Ratio | -4.9 |
Price to Sales Ratio | 499.23 |
Price to Cash Ratio | 12.49 |
Price to Book Ratio | 1.67 |
Dividend Yield | - |
Shares Outstanding | 60.85M |
Average Volume (1 week) | 739.6k |
Average Volume (1 Month) | 487.61k |
52 Week Change | -6.80% |
52 Week High | 19.62 |
52 Week Low | 10.22 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.